Deep Margin
Nadeem Riaz directs the Precision Radiotherapy Initiative and leads a multidisciplinary research lab at the intersection of the DNA damage response and anti-tumor immunity. He talks us through his important paper examining mechanisms of resistance and some of the pitfalls of academia.
21 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity Deep Margin-yhteisöön!